Lunai Bioworks Inc.
LNAI
$1.25
-$0.01-0.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 106.38% | -705.59% | 100.32% | -60.13% | -381.87% |
| Total Depreciation and Amortization | 28.09% | 4.82% | 5.61% | -3.31% | 18.68% |
| Total Amortization of Deferred Charges | -21.94% | -100.00% | -100.00% | -95.78% | -85.88% |
| Total Other Non-Cash Items | -113.02% | 1,197.55% | -105.83% | 268.24% | 619.84% |
| Change in Net Operating Assets | -50.56% | -57.96% | -69.62% | 533.68% | 220.75% |
| Cash from Operations | 33.09% | 24.97% | 43.52% | 18.65% | 27.40% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 3,336.24% | -862.16% | -- | -- |
| Cash from Investing | -- | 1,905.99% | -1,498.69% | -- | -- |
| Total Debt Issued | 929.32% | 28.22% | -54.11% | -8.21% | -79.08% |
| Total Debt Repaid | -21.30% | -21.30% | -21.30% | 13.19% | -19.60% |
| Issuance of Common Stock | -- | -- | 200.00% | -18.10% | 4.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.80% | -92.77% | 35.71% | -8.99% | -20.82% |
| Foreign Exchange rate Adjustments | 46.88% | -76.36% | -113.85% | -22.81% | 83.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 532,000.00% | -800.54% | 789.67% | 132.63% | 100.01% |